Arteris (AIP) Cash & Equivalents (2021 - 2026)

Arteris has reported Cash & Equivalents for 6 years, with the latest figure at $11.7 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 28.69% year-over-year to $11.7 million; the trailing twelve-month figure through Mar 2026 stood at $11.7 million (down 28.69% YoY), and the FY2025 full-year result was $33.9 million, up 147.74% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $11.7 million, down from $33.9 million in the prior quarter.
• The five-year high for Cash & Equivalents was $82.2 million in Q1 2022, with the low at $11.7 million in Q1 2026.
• Historically, Cash & Equivalents has averaged $31.3 million across 5 years, with a median of $22.1 million in 2024.
• Annual changes were most pronounced in 2022 — Cash & Equivalents surged 506.71% — and 2023, when it plunged 72.69%.
• Arteris' Cash & Equivalents stood at $37.4 million in 2022, then tumbled by 63.4% to $13.7 million in 2023, then slipped by 0.09% to $13.7 million in 2024, then soared by 147.74% to $33.9 million in 2025, then tumbled by 65.56% to $11.7 million in 2026.
• The last three Cash & Equivalents figures came in at $11.7 million (Q1 2026), $33.9 million (Q4 2025), and $17.4 million (Q3 2025), per Business Quant data.